[Asia Economy Reporter Minwoo Lee] Enbionia announced on the 9th that it has decided to acquire 200,000 shares of Cefratech worth 1 billion KRW by participating in a third-party allotment paid-in capital increase. Enbionia stated, "The goal is to enter the membrane market by securing membrane technology and to create synergy with existing businesses."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

